Autor: "Dabis, Francois" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial.
Autorzy:: Baisley K; Africa Health Research Institute, Durban, South Africa.; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Orne-Gliemann J; University of Bordeaux, Inserm, Institut de Recherche pour le Développement (IRD), UMR 1219, Bordeaux, France.
Larmarange J; Centre Population et Développement (Ceped), Institut de Recherche pour le Développement (IRD), Université de Paris, Inserm, Paris, France.
Plazy M; University of Bordeaux, Inserm, Institut de Recherche pour le Développement (IRD), UMR 1219, Bordeaux, France.
Collier D; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
Dreyer J; Africa Health Research Institute, Durban, South Africa.
Mngomezulu T; Africa Health Research Institute, Durban, South Africa.
Herbst K; Africa Health Research Institute, Durban, South Africa.; DSI-MRC South African Population Research Infrastructure Network, Durban, South Africa.
Hanekom W; Africa Health Research Institute, Durban, South Africa.; Division of Infection and Immunity, University College London, London, UK.
Dabis F; University of Bordeaux, Inserm, Institut de Recherche pour le Développement (IRD), UMR 1219, Bordeaux, France.
Siedner MJ; Africa Health Research Institute, Durban, South Africa.; Harvard Medical School, Boston, Massachusetts, USA.
Iwuji C; Africa Health Research Institute, Durban, South Africa.; Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; Pokaż więcej
Źródło:: HIV medicine [HIV Med] 2022 Sep; Vol. 23 (8), pp. 922-928. Date of Electronic Publication: 2022 Feb 26.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/epidemiology
Humans ; South Africa/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Measuring retention in care for HIV-positive pregnant women in Prevention of Mother-to-Child Transmission of HIV (PMTCT) option B+ programs: the Mozambique experience.
Autorzy:: Ahoua L; University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Team IDLIC, UMR 1219, Université de Bordeaux, Case 11, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France. laurence_.; Mailman School of Public Health, ICAP at Columbia University, Rua Francisco Matange, 224/246, Caixa Postal n.°1747, Maputo, Mozambique. laurence_.
Arikawa S; University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Team IDLIC, UMR 1219, Université de Bordeaux, Case 11, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.
Tiendrebeogo T; University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Team IDLIC, UMR 1219, Université de Bordeaux, Case 11, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.
Lahuerta M; ICAP at Columbia University, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, USA.
Aly D; Mailman School of Public Health, ICAP at Columbia University, Rua Francisco Matange, 224/246, Caixa Postal n.°1747, Maputo, Mozambique.
Becquet R; University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Team IDLIC, UMR 1219, Université de Bordeaux, Case 11, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.
Dabis F; University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Team IDLIC, UMR 1219, Université de Bordeaux, Case 11, 146 rue Léo Saignat, 33076, Bordeaux Cedex, France.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2020 Mar 12; Vol. 20 (1), pp. 322. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents/*therapeutic use
HIV Infections/*prevention & control
Infectious Disease Transmission, Vertical/*prevention & control
Pregnancy Complications, Infectious/*prevention & control
Retention in Care/*statistics & numerical data
Adult ; Female ; Follow-Up Studies ; HIV Infections/transmission ; Humans ; Infant ; Mozambique ; Pregnancy ; Program Evaluation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
Autorzy:: Havlir D; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Lockman S; Brigham and Women's Hospital, Boston, MA, USA.; Harvard School T.H. Chan School of Public Health, Boston, MA, USA.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Ayles H; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Zambart, Lusaka, Zambia.
Larmarange J; Centre Population et Développement, Institut de Recherche pour le Développement, Université Paris Descartes, Inserm, Paris, France.; Africa Health Research Institute, Somkhele, South Africa.
Chamie G; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Gaolathe T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; University of Botswana, Gaborone, Botswana.
Iwuji C; Department of Global Health & Infection, Brighton and Sussex Medical School, Brighton, United Kingdom.; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Research Department of Infection and Population Health, University College London, London, United Kingdom.
Fidler S; Imperial College, National Institute for Health Research Biomedical Research Center, London, United Kingdom.; Department of Infectious Disease, Imperial College London, London, United Kingdom.
Kamya M; Department of Medicine, Makerere University, Kampala, Uganda.; Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Floyd S; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Moore J; Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hayes R; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Petersen M; School of Public Health, University of California Berkeley, Berkeley, CA, USA.
Dabis F; ISPED & Inserm Bordeaux Population Health UMR 1219, Univ Bordeaux, Bordeaux, France.; Pokaż więcej
Corporate Authors:: (Universal Test, Treat Trials) UT3 Consortium
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2020 Feb; Vol. 23 (2), pp. e25455.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Mass Screening*
Anti-HIV Agents/*therapeutic use
Epidemics/*prevention & control
HIV Infections/*prevention & control
AIDS Serodiagnosis ; Adolescent ; Adult ; Botswana/epidemiology ; Female ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Humans ; Incidence ; Kenya/epidemiology ; Male ; Prevalence ; Public Health ; South Africa/epidemiology ; Time-to-Treatment ; Uganda/epidemiology ; Viral Load ; Zambia/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
Autorzy:: Iwuji C; Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK.; Africa Health Research Institute, Durban, South Africa.; Institute for Global Health, University College London, London, UK.
McGrath N; Africa Health Research Institute, School of Nursing & Public Health, University of KwaZulu- Natal, KwaZulu-Natal, South Africa.; Faculty of Medicine and Faculty of Human, Social and Mathematical Sciences, University of Southampton, Southampton, UK.; Research Department of Epidemiology & Public Health, University College London, London, UK.
Calmy A; Service des Maladies Infectieuses, HIV Unit, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Dabis F; Centre INSERM U1219, Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Pillay D; Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK.; Division of Infection and Immunity, University College London, London, UK.
Newell ML; Human Development and Health and Global Health Research Institute, Faculty of Medicine, University of Southampton, Southampton, UK.
Baisley K; Department of Global Health and Infection, Brighton and Sussex Medical School, Brighton, UK.; Department of Infectious Disease Epidemiology, Faculty of Epidemiology & Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Porter K; Institute for Global Health, University College London, London, UK.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2018 Jun; Vol. 21 (6), pp. e25112.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Medication Adherence*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Adult ; CD4 Lymphocyte Count ; Female ; HIV Infections/immunology ; HIV Infections/virology ; Humans ; Logistic Models ; Male ; Middle Aged ; Prospective Studies ; South Africa/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Optimal breastfeeding durations for HIV-exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk.
Autorzy:: Mallampati D; Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL, USA.
MacLean RL; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Divisions of General Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Shapiro R; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Immunology and Infectious Diseases, Harvard T.H, Chan School of Public Health, Boston, MA, USA.; The Botswana-Harvard School of Public Health AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana.
Dabis F; Université Bordeaux, Institut de Santé Publique, d'Epidémiologie et de Dévelopement (ISPED), Centre INSERM, U1219-Bordeaux Population Health, Bordeaux, France.
Engelsmann B; Organization for Public Health Interventions and Development, Harare, Zimbabwe.
Freedberg KA; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Divisions of General Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Harvard University Center for AIDS Research Boston, MA, USA.
Leroy V; Inserm U1027, University of Toulouse 3, Toulouse, France.
Lockman S; Department of Immunology and Infectious Diseases, Harvard T.H, Chan School of Public Health, Boston, MA, USA.; The Botswana-Harvard School of Public Health AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.
Walensky R; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Divisions of General Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Harvard University Center for AIDS Research Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Rollins N; Department of Maternal Newborn, Child and Adolescent Health World Health Organization, Geneva, Switzerland.
Ciaranello A; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2018 Apr; Vol. 21 (4), pp. e25107.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Feeding*
Infant Mortality*
Anti-HIV Agents/*therapeutic use
HIV Infections/*transmission
Female ; HIV Infections/drug therapy ; Humans ; Infant ; Infant, Newborn ; Infectious Disease Transmission, Vertical/prevention & control ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Autorzy:: Tymejczyk O; Institute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.; Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America.
Brazier E; Institute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.; Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America.
Yiannoutsos C; R.M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, United States of America.
Wools-Kaloustian K; Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Althoff K; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Crabtree-Ramírez B; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Van Nguyen K; National Hospital of Tropical Diseases, Hanoi, Vietnam.
Zaniewski E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Dabis F; Bordeaux School of Public Health, Bordeaux, France.
Sinayobye JD; Rwanda Military Hospital, Kigali, Rwanda.
Anderegg N; National Hospital of Tropical Diseases, Hanoi, Vietnam.
Ford N; World Health Organization, Geneva, Switzerland.
Wikramanayake R; Institute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.; Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America.
Nash D; Institute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.; Graduate School of Public Health and Health Policy, City University of New York, New York, New York, United States of America.; Pokaż więcej
Corporate Authors:: IeDEA Collaboration
Źródło:: PLoS medicine [PLoS Med] 2018 Mar 23; Vol. 15 (3), pp. e1002534. Date of Electronic Publication: 2018 Mar 23 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Health Services Accessibility*
Time-to-Treatment*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Adolescent ; Adult ; CD4 Lymphocyte Count ; Female ; HIV Infections/epidemiology ; Humans ; International Cooperation ; Longitudinal Studies ; Male ; Middle Aged ; Prospective Studies ; Regression Analysis ; Retrospective Studies ; World Health Organization ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa.
Autorzy:: Leroi C; Bordeaux University, School of Public Health (ISPED), Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.; INSERM, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.
Balestre E; Bordeaux University, School of Public Health (ISPED), Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.; INSERM, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.
Messou E; Programme PAC-CI, CHU de Treichville, Abidjan, Côte d'Ivoire.; Centre de Prise en charge de Recherche et de Formation, Hôpital Yopougon Attié, Abidjan, Côte d'Ivoire.
Minga A; Centre Médical de Suivi de Donneurs de Sang /CNTS/PRIMO-CI, Abidjan, Cote d'Ivoire.
Sawadogo A; Département de maladies infectieuses, CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso.
Drabo J; Service de Médecine interne, CHU Yalgado Ouedraogo (CHU-YO), Ouagadougou, Burkina Faso.
Maiga M; Service d'Hépato-Gastro-Entérologie, Hôpital Gabriel Touré, Bamako, Mali.
Zannou M; Centre de Prise en Charge des Personnes vivant avec le VIH, CNHU, Cotonou, Benin.
Seydi M; Service de maladies infectieuses et tropicales, CRCF, CHU de Fann, Dakar, Sénégal.
Dabis F; Bordeaux University, School of Public Health (ISPED), Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.; INSERM, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.
Jaquet A; Bordeaux University, School of Public Health (ISPED), Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.; INSERM, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.; Pokaż więcej
Corporate Authors:: IeDEA West Africa collaboration
Źródło:: PloS one [PLoS One] 2017 Jan 25; Vol. 12 (1), pp. e0170753. Date of Electronic Publication: 2017 Jan 25 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents/*adverse effects
Antiretroviral Therapy, Highly Active/*adverse effects
Neutropenia/*chemically induced
Neutropenia/*epidemiology
Zidovudine/*adverse effects
Adult ; Africa, Western/epidemiology ; Anti-HIV Agents/therapeutic use ; Female ; HIV Infections/drug therapy ; Humans ; Incidence ; Male ; Neutropenia/diagnosis ; Retrospective Studies ; Severity of Illness Index ; Zidovudine/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.
Autorzy:: Iwuji CC; Africa Centre for Population Health, University of KwaZulu-Natal, Durban, South Africa.; Research Department of Infection and Population Health, University College London, London, United Kingdom.
Orne-Gliemann J; Centre INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.; Institut de Santé Publique, d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Larmarange J; Africa Centre for Population Health, University of KwaZulu-Natal, Durban, South Africa.; Centre Population & Développement UMR 196, Université Paris Descartes, Institut de Recherche pour le Développement, Paris, France.
Okesola N; Africa Centre for Population Health, University of KwaZulu-Natal, Durban, South Africa.
Tanser F; Africa Centre for Population Health, University of KwaZulu-Natal, Durban, South Africa.; School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Thiebaut R; Centre INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.; Institut de Santé Publique, d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.
Rekacewicz C; Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Paris, France.
Newell ML; Africa Centre for Population Health, University of KwaZulu-Natal, Durban, South Africa.; Human Health and Development and Global Health Research Institute, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Dabis F; Centre INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.; Institut de Santé Publique, d'Epidémiologie et de Développement, Centre INSERM U1219 Bordeaux Population Health, Université de Bordeaux, Bordeaux, France.; Pokaż więcej
Corporate Authors:: ANRS 12249 TasP trial group
Źródło:: PLoS medicine [PLoS Med] 2016 Aug 09; Vol. 13 (8), pp. e1002107. Date of Electronic Publication: 2016 Aug 09 (Print Publication: 2016).
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Attitude to Health*
Continuity of Patient Care*/organization & administration
AIDS Serodiagnosis/*methods
Anti-HIV Agents/*therapeutic use
HIV Infections/*diagnosis
Self Care/*methods
Adult ; Female ; HIV Infections/drug therapy ; HIV Infections/psychology ; Humans ; Male ; Middle Aged ; Rural Population/statistics & numerical data ; Sexual Partners ; South Africa/epidemiology ; Young Adult